We studied the effect of antibodies against Porphyromonas gingivalis gingipain domains, preparing them against three recombinant fragments of RgpA (catalytic domain: r-Rgp CAT; hemagglutinin domains: r-Rgp 44 and r-Rgp 15-27) and one fragment of Kgp (catalytic domain: r-Kgp CAT). Enhancement of opsonization, and killing by human polymorphonuclear leukocytes was measured in the non-invasive FDC 381 and invasive W50 strains of P. gingivalis. Anti-r-Rgp 44 antibody was the most effective in both strains of P. gingivalis. The present findings recommend RgpA 44 as a candidate immunogen for vaccines against P. gingivalis.
Introduction
Porphyromonas gingivalis has been implicated as a major etiologic bacterium in the progression of human periodontal disease [1] . This microorganism has several virulence factors, such as fimbriae [2] , hemagglutinins [3, 4] lipopolysaccharides (LPS) [5] , and extra-cellular and cell-associated cysteine proteinases [6, 7] . The cysteine proteases, in particular, are believed to play a major role in the progression of human periodontal disease [8] , especially in the colonization and inactivation of host defenses, tissue destruction, and modulation of host immune systems [9] .
Surface proteases have also been reported as major virulence factors for this microorganism [10] , and the most important surface protease among these is gingipain.
Gingipain appears to consist of both arginine-and lysine-specific cysteine proteinases (RgpA and RgpB, and Kgp, respectively) [11, 12] . RgpA and Kgp consist of a prepropeptide domain, a catalytic domain and an adhesion/hemagglutinin domain.
Most of the C-terminal adhesion/hemagglutinin domain is absent in RgpB. However, although the catalytic domains of RgpA and Kgp are divergent, their adhesion/hemagglutinin domain regions are very similar [11, 13, 14] .
Rgps degrade host proteins such as collagen, prokallikrein and fibronectin.
They also degrade molecules associated with host defense systems, such as immunoglobulin and IL-12 [15, 16] . Rgps activate several mediators involved in inflammation, including those associated with the chemotaxis of polymorphonuclear leukocytes, by generating C5a and inducing the release of bradykinin through activation of prekallikrein [17, 18] , activities which result in dysfunction of host defense systems.
Kgp degrades fibrinogen, IL-6, and the adherence junctions of epithelial cells [19, 20] .
In addition, Kgp can bind hemoglobin, an important source of iron for these organisms [21] . The above results indicate that gingipains are important factors in iron acquisition, adherence to host cells, destruction of epithelial barriers, and disruption of the immune system. P. gingivalis strains are classified as invasive (e.g., strains W50 and A7A1- 28) or non-invasive (e.g., strains ATCC 33277 and FDC 381), based on their ability to cause the spread of ulcerative lesions distant from injection sites or localized abscesses at sites of injection in murine models, respectively [22, 23] .
A vaccine targeting their proteases might provide protection against both strains. Gingipains are considered potential targets in the development of vaccines against periodontal disease. Therefore, the identification and testing of purified recombinant components of P. gingivalis for use as antigens in a vaccine against periodontitis would be a major step in the development of such vaccines. Of the P. gingivalis components studied to date, gingipains have been shown to possess the greatest potential for preventing the initiation and progression of periodontal diseases [24] [25] [26] . However, the antigenic properties of these proteins have yet to be extensively characterized. Therefore, the primary purpose of this study was to clarify the protective effect of anti-recombinant gingipain domain antibodies against both invasive and non-invasive strains of P.
gingivalis.
Materials and Methods

1. Preparation of recombinant gingipains
Preparation of recombinant gingipains was carried out as described previously [27] , and involved the functional domains of these proteases (Fig. 1) antigen-specific immunoglobulins were defined as the last dilutions producing an optical density at 490 nm of >0.08.
4. Chemiluminescence assay of opsonization
In the present study, P. gingivalis FDC 381 and P. gingivalis W50 were used as typically representative non-invasive and invasive strains, respectively. P. Chemiluminescence assays were performed as described by Nakagawa et al. [31] . After obtaining informed consent, 60 ml of venous blood were obtained from anti-r-Kgp CAT antibody at 7.5 mg/ml were also pre-incubated at 37 o C for 10 min.
These two solutions were then mixed. Next, 10 µl of CaCl 2 (100 mM) and 10 µl of a C5-depleted human serum were added to the resulting solution (total assay volume 1 ml). This was then transferred to chemiluminescence test tubes. Measurements of chemiluminescence were performed using an Auto-LUMICOUNTER Model 1422EX
(Microtech-Nichion, Funabashi, Japan) at 37 o C for 135 min. Degree of opsonization was expressed in relative luminescent units (rlu).
5. Antibody enhancement of PMN bactericidal activity
Antibody enhancement of PMN bactericidal activity was evaluated as described by Nakagawa et al. [31] . The components described above for the chemiluminescence assay were added in the same order, but with increased GGVB ++ in place of the working luminol solution. One hundred fifty µl of PMN (1. 
6. Statistical Analysis
The difference in the peak values for chemiluminescent activity and percentage of remaining viable bacteria were assessed with a Mann-Whitney U test.
Results
1. Purification of anti-recombinant gingipain domain antibodies
We These rabbit antisera against recombinant gingipains reacted against the whole-cell extracts of P. gingivalis FDC 381 (Fig. 3) . Anti-r-Rgp CAT antibody showed a strongly immunoreactive response to the 45-kDa protein band (Fig. 3, lane 1) .
Similarly, anti-r-Rgp 44 antibody reacted strongly with 42 kDa (Fig. 3, lane 2) , and anti-r-Rgps 15-27 antibody also reacted strongly with 54 kDa (Fig. 3, lane 3) . In addition, anti-r-Kgp CAT reacted with cellular extracts of P. gingivalis FDC 381, and here we found a band of approximately 50 kDa in size (Fig. 3, lane 4) . These sizes were almost identical to the size of each domain as estimated from their amino acid sequences [11, 14, 15] . We also found extra bands: anti-r-Rgp CAT antibody reacted showing a band of about 50 kDa ( 
2. Antibody titers as assessed by ELISA
The Table 1 . The titer of anti-P. gingivalis whole-cell antibody was higher than that for the other antibodies elicited by the recombinant proteins. The titer of anti-r-Rgp 44
antibody was higher than that for the other anti-recombinant antibodies.
Chemiluminescence of opsonization
Five to 7 sets of experiments, depending on strain, were performed to assess the capacity of the antibodies against P. gingivalis whole cells and the capacity of the 4 recombinant gingipain domains to opsonize the 2 strains of P. gingivalis, FDC 381 and W50. To obtain a control reaction, PMN and bacteria were incubated with pre-immune sera. They were also incubated without IgG, both with and without complement. No peak was observed when PMN was incubated without IgG, either with or without complement, or when incubated with pre-immune sera (data not shown). was the highest, and the mean peaks were almost the same in both the invasive and non-invasive strains (Table 2) .
4. Antibody enhancement of PMN bactericidal activity
To measure the extent to which the antibodies enhanced the killing of bacterial cells by PMN, the number of surviving bacteria at the end of the incubations was determined by viability counting. The results are summarized in Fig. 4 as the percentage of viable bacteria remaining at the end of the incubation period compared with in incubations containing bacteria only. Antibody enhancement of the killing of the FDC 381 strain is shown in Fig. 4A , and the killing of the W50 strain is shown in Fig. 4B . Anti-P.
gingivalis whole-cell and anti-r-Rgp 44 antibodies showed a significantly stronger enhancement of killing than that elicited by pre-immune sera in the FDC 381 strain (P<0.0001: anti-P. gingivalis whole-cell antibody; P<0.05: anti-r-Rgp 44 antibody).
We also observed that antibodies against P. gingivalis whole-cell and r-Rgp 44 antibody were significantly more effective than pre-immune sera in enhancing killing against invasive W50 strains (P<0.001: anti-P. gingivalis whole-cell antibody; P<0.05:
anti-r-Rgp 44 antibody). However, antibodies against r-Rgp CAT, r-Rgps 15-27, and r-Kgp CAT showed no significant difference to pre-immune sera in the enhancement of PMN-mediated bacteriocidal activity against either strain of P. gingivalis.
Discussion
Among the 4 anti-recombinant gingipain antibodies tested against sonic extracts of P. gingivalis, the titer of anti-r-Rgp 44 antibody was higher than that for the anti-r-Rgp CAT, anti-r-Rgps 15-27, or anti-r-Kgp CAT antibodies. The results showed that, among the antibodies to the domains of gingipain, anti-Rgp44 antibody had the strongest reactivity to P. gingivalis whole cells, while the catalytic domain of Rgp was the lowest. These results agree with our previous findings showing that the catalytic domains of RgpA and Kgp were not the predominant antigens in patients with periodontitis [27] . Recent reports have also shown that the immunogenicity of the catalytic domain is low compared with that of the hemagglutinin domain [25, [32] [33] [34] .
However, the titers of these antibodies against each homologous recombinant protein were almost the same. The results showed that some of the epitopes of the recombinant gingipain catalytic domains were scarcely exposed on the surface of the A recent report has shown that immunization with RgpA stimulated the production of hemagglutinin domain-specific antibodies, and that this contributed to the attenuation of P. gingivalis-mediated oral bone loss in a murine oral challenge model. It also showed that this antibody recognized a 44 kDa protein in P. gingivalis lysates [32] .
Booth et al. [34] reported that passive immunization with monoclonal antibodies against P. gingivalis prevented re-colonization of this microorganism in patients with periodontitis. Booth et al. [24, 37] showed that the monoclonal antibody appeared to react with the hemagglutinin domain of RgpA. It is possible that the antibody against r-Rgp 44 in this study contained an antibody with the same specificity to that of the monoclonal antibody used by Booth et al. [24, 37] . O'Brien-Simpson et al. [33, 38] suggested that epitopes within RgpA 27, Kgp 39, and RgpA 44 might induce protection, based on the results of both human and mouse studies, along with studies on immunization targeting the Rgp-Kgp proteinases-adhesion complex. Yonezawa et al. [26] in our laboratory have demonstrated that the antibody response against the catalytic subunit of RgpA was low compared with that against the hemagglutinin domain in mice immunized with a DNA vaccine containing the entire RgpA gene. Furthermore, they also showed that sera from mice immunized with the rgpA DNA vaccine reduced the hemagglutinin activity of P. gingivalis. These reports of O'Brien-Simpson et al. [33, 38] and Yonezawa et al. [26] suggest that the 44kDa hemagglutinin domain may represent a functionally important target for the host specific immune response to P.
gingivalis in periodontal disease. That is to say, antibodies against the hemagglutinin domain, including RgpA 44, exert a protective effect against infection with P. gingivalis.
The results of the present study showed that the titer of anti-r-Rgp 44 antibody was highest among the titers of the anti-recombinant gingipain antibodies, and that it strongly induced opsonization against both non-invasive and invasive strains of P.
gingivalis. In addition, anti-r-Rgp 44 antibody was found to strongly induce the killing of P. gingivalis by neutrophils. These data suggest that antibody directed to the RgpA 44 domain is capable of inducing a protective immune response against infection by strains of P. gingivalis. However, antibody levels against r-Rgp 44 and r-Rgps 15-27
are relatively high in patients with periodontitis [27] . In order to clarify this discrepancy, further study is needed to evaluate antibody subclasses and opsonization in serum from periodontitis patients.
The catalytic domains of gingipains have also been demonstrated to induce protective antibodies [21, 25] . Genco et al. [25] showed that antibodies directed to the amino-terminal region of the catalytic domain of RgpA were capable of inducing a protective immune response against infection with P. gingivalis in a mouse chamber model. Kuboniwa et al. [21] also showed that a DNA vaccine encoding the catalytic subunits of RgpA and Kgp induced protective effects against infection with P. gingivalis in a mouse model. They also suggested that Kgp CAT was a more promising candidate for a future vaccine than RgpA CAT. In our present study, both anti-r-Rgp CAT and anti-r-Kgp CAT induced opsonization. However, only anti-r-Kgp CAT induced the same level of opsonization against both invasive and non-invasive strains. The killing activity of the anti-r-Kgp CAT antibody in P. gingivalis FDC 381 was between that of anti-r-Rgp 44 and anti-r-Rgp CAT, although there was no significant difference with that of pre-immune sera. Anti-r-Rgp 44 showed the strongest performance in the killing of P. gingivalis W50, followed by anti-r-Rgp CAT antibody, although there was no significant difference in this case to that in pre-immune sera. This discrepancy between our report and other reports may have been caused by the difference in antibody titers. The titers of anti-r-Rgp CAT and anti-r-Kgp CAT antibodies against P.
gingivalis whole cell in the present study were lower than the antibody against r-Rgp 44.
Curtis et al. [39] reported that the catalytic subunit of native Rgp was glycosylated and that the epitopes of the subunit were different to those of recombinant catalytic subunits.
This difference must have caused the discrepancy. Further study on immunogen and immunization routes is necessary to ascertain efficient antibody titers against the catalytic domains of gingipains.
In conclusion, the present study demonstrated that the immunogenicity of hemagglutinin domain RgpA 44 was relatively high, and suggests that this domain is a suitable candidate as an immunogen in the development of vaccines against strains of P.
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